Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| TGENOME | BCARERMF | |
|---|---|---|
| Only in TGENOME | ||
| 8.90% | N/A | |
| 7.84% | N/A | |
| 6.99% | N/A | |
| 4.10% | N/A | |
| Only in BCARERMF | ||
| N/A | 8.45% | |
| N/A | 5.47% | |
| N/A | 4.77% | |
| N/A | 3.88% | |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TGENOME | +63.50% | 40.04% | 1.59 |
| BCARERMF | +15.33% | 16.01% | 0.96 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | TGENOME | BCARERMF |
|---|---|---|
Fund details | ||
| Fund size | 1,343 million | 8,627 million |
| Inception date | 13 Jan 2021 | 19 May 2015 |
| Master fund | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution, iShares Genomics Immunology and Healthcare, ISHARES BIOTECHNOLOGY) | Wellington Global Health Care Equity Fund |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 84.93% | 45.53% |
Minimum purchase and redemption | ||
| First purchase | 1,000 THB | 500 THB |
| Subsequent purchase | 1,000 THB | 500 THB |
| Redemption (amount) | No minimum | No minimum |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | No minimum |
| Balance (units) | No minimum | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:30 |
| Redeem before | 15:30 | 15:30 |
| Redemption paid | T+3 | T+4 |